This federal contract award, SPE2DB22D1106|SPE2DB25FDJP3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,212.70 firm fixed-price delivery order is for the supply of 4566293159 CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. There is no set-aside designation specified. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 1/30/25, 9:18 AM